OpenAlex
PricingAboutJobs
Log inGet started
Work

A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first-line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial

HTML PDF

Year: 2015
Type: article
Source: Annals of Oncology
DOI: 10.1093/annonc/mdv490
Authors: H. Hagman, J.-E. Frödin, Å. Berglund, J. Sundberg, L.W. Vestermark, M. Albertsson, E. Fernebro, A. Johnsson
Institutions: Ryhov Hospital Jönköping, Karolinska University Hospital, Uppsala University Hospital, Skåne University Hospital, Odense University Hospital, Linköping University Hospital, Växjö Kommun
Language: English

Topic: Colorectal Cancer Treatments and Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: metastatic colorectal cancer, maintenance therapy, KRAS mutation status, bevacizumab, erlotinib, metronomic capecitabine, XELOX, FOLFOX, XELIRI, FOLFIRI, progression-free survival, overall survival, treatment toxicity, biomarker-guided therapy
SDG: Good health and well-being

Open Access status: bronze

Funders: Skåne County Council's Research and Development Foundation, Futurum - Akademin för Hälsa och Vård, Region Jönköpings läns
OpenAlex ID: W2126573891
FWCI: 3.314
Cites: 14
Cited by: 56
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security